These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 17532058

  • 1. T-cell Ig and mucin domain-containing protein (Tim)-2 regulates murine allergic conjunctivitis during the effector phase.
    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Okumura K, Akiba H, Yagita H, Ueno H.
    Immunol Lett; 2007 Jun 15; 110(2):133-8. PubMed ID: 17532058
    [Abstract] [Full Text] [Related]

  • 2. Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice.
    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Okumura K, Akiba H, Yagita H, Ueno H.
    Int Arch Allergy Immunol; 2008 Jun 15; 146(1):36-43. PubMed ID: 18087160
    [Abstract] [Full Text] [Related]

  • 3. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Yagita H, Ueno H.
    Invest Ophthalmol Vis Sci; 2006 Feb 15; 47(2):657-63. PubMed ID: 16431965
    [Abstract] [Full Text] [Related]

  • 4. B7-H3 regulates the development of experimental allergic conjunctivitis in mice.
    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Yamazaki T, Akiba H, Okumura K, Yagita H, Ueno H.
    Immunol Lett; 2007 Oct 31; 113(1):52-7. PubMed ID: 17825429
    [Abstract] [Full Text] [Related]

  • 5. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Ueno H.
    Int Arch Allergy Immunol; 2007 Oct 31; 144(1):79-84. PubMed ID: 17505142
    [Abstract] [Full Text] [Related]

  • 6. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
    Fukushima A, Sumi T, Ishida W, Yamada J, Iwakura Y, Ueno H.
    Int Arch Allergy Immunol; 2008 Oct 31; 147(3):206-12. PubMed ID: 18594150
    [Abstract] [Full Text] [Related]

  • 7. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
    Sumi T, Fukushima A, Nishino K, Fukuda K, Kumagai N, Nishida T, Ueno H.
    Cell Biol Int; 2009 Apr 31; 33(4):534-41. PubMed ID: 19230848
    [Abstract] [Full Text] [Related]

  • 8. Antibodies to T-cell Ig and mucin domain-containing proteins (Tim)-1 and -3 suppress the induction and progression of murine allergic conjunctivitis.
    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Akiba H, Okumura K, Yagita H, Ueno H.
    Biochem Biophys Res Commun; 2007 Feb 02; 353(1):211-6. PubMed ID: 17174273
    [Abstract] [Full Text] [Related]

  • 9. Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice.
    Fukushima A, Ozaki A, Jian Z, Ishida W, Fukata K, Ueno H, Liu FT.
    Curr Eye Res; 2005 Apr 02; 30(4):241-8. PubMed ID: 15823916
    [Abstract] [Full Text] [Related]

  • 10. Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis.
    Sumi T, Ishida W, Mittler RS, Yagita H, Taguchi O, Fukushima A.
    Int Arch Allergy Immunol; 2009 Apr 02; 148(4):305-10. PubMed ID: 19001790
    [Abstract] [Full Text] [Related]

  • 11. Differential contributions of B7-1 and B7-2 to the development of murine experimental allergic conjunctivitis.
    Sumi T, Fukushima A, Fukuda K, Kumagai N, Nishida T, Yagita H, Ueno H.
    Immunol Lett; 2007 Jan 15; 108(1):62-7. PubMed ID: 17109973
    [Abstract] [Full Text] [Related]

  • 12. Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Taniguchi T, Liu FT, Ueno H.
    Exp Eye Res; 2006 Feb 15; 82(2):210-8. PubMed ID: 16102751
    [Abstract] [Full Text] [Related]

  • 13. Role of VLA-4 in the development of allergic conjunctivitis in mice.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Ueno H.
    Mol Vis; 2006 Apr 07; 12():310-7. PubMed ID: 16617298
    [Abstract] [Full Text] [Related]

  • 14. Activation of tumour-necrosis factor-related apoptosis-inducing ligand receptor enhances the severity of murine allergic conjunctivitis.
    Sumi T, Ishida W, Okumura K, Yagita H, Fukushima A.
    Br J Ophthalmol; 2009 Jan 07; 93(1):110-5. PubMed ID: 18782797
    [Abstract] [Full Text] [Related]

  • 15. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
    Fukushima A, Ishida W, Ojima A, Kajisako M, Sumi T, Yamada J, Tsuru E, Miyazaki J, Tominaga A, Yagita H.
    Int Arch Allergy Immunol; 2010 Jan 07; 151(2):129-36. PubMed ID: 19752566
    [Abstract] [Full Text] [Related]

  • 16. The interaction between ICOS and B7RP-1 is not required for the development of experimental murine allergic conjunctivitis.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Yagita H, Ueno H.
    Biochem Biophys Res Commun; 2005 Dec 30; 338(4):1726-31. PubMed ID: 16289109
    [Abstract] [Full Text] [Related]

  • 17. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
    Stern ME, Siemasko K, Gao J, Duong A, Beauregard C, Calder V, Niederkorn JY.
    Invest Ophthalmol Vis Sci; 2005 Sep 30; 46(9):3239-46. PubMed ID: 16123425
    [Abstract] [Full Text] [Related]

  • 18. Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis.
    Fukushima A, Sumi T, Ishida W, Ojima A, Kajisako M, Koyanagi A, Koyama N, Yagita H.
    Immunol Lett; 2008 Dec 22; 121(2):140-7. PubMed ID: 19027794
    [Abstract] [Full Text] [Related]

  • 19. Modulation of murine experimental allergic conjunctivitis by treatment with alpha-galactosylceramide.
    Fukushima A, Sumi T, Fukuda K, Yamaguchi T, Kumagai N, Nishida T, Ueno H.
    Immunol Lett; 2006 Sep 15; 107(1):32-40. PubMed ID: 16930723
    [Abstract] [Full Text] [Related]

  • 20. Thymus-derived CD4+ CD25+ T cells suppress the development of murine allergic conjunctivitis.
    Sumi T, Fukushima A, Fukuda K, Kumagai N, Nishida T, Takeuchi M, Taguchi O, Ueno H.
    Int Arch Allergy Immunol; 2007 Sep 15; 143(4):276-81. PubMed ID: 17356295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.